In this episode of the DrBicuspid.com podcast, Kevin Henry speaks with Dr. Yoon Hong Cheol and Dr. Mike Miyasaki about the innovative biofluorescence technology developed by AIOBIO. They discuss the shift from reactive to preventive dentistry, the importance of building trust with patients through visual tools, and the commitment required for success in the dental field. The conversation also touches on the goals for 2026, focusing on expanding the use of biofluorescence technology in the United States.
Learn more at https://www.aiobio.com/home
All content for DrBicuspid is the property of DrBicuspid and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In this episode of the DrBicuspid.com podcast, Kevin Henry speaks with Dr. Yoon Hong Cheol and Dr. Mike Miyasaki about the innovative biofluorescence technology developed by AIOBIO. They discuss the shift from reactive to preventive dentistry, the importance of building trust with patients through visual tools, and the commitment required for success in the dental field. The conversation also touches on the goals for 2026, focusing on expanding the use of biofluorescence technology in the United States.
Learn more at https://www.aiobio.com/home
The economic outlook for dentistry: What one dental executive is watching and thinking
DrBicuspid
13 minutes 21 seconds
3 weeks ago
The economic outlook for dentistry: What one dental executive is watching and thinking
In this episode sponsored by GC America, Joe Talanges, President and COO of GC America, discusses the current state and future of the dental industry, focusing on economic trends, patient care, and the importance of collaboration among industry leaders. He emphasizes the need for innovation and healthy competition to improve patient outcomes and addresses the challenges of patient coverage and the impact of tariffs on the industry. Looking ahead to 2026, Talanges expresses hope for advancements in technology and increased patient access to dental care.
Learn more about GC America at https://www.gc.dental/america/
DrBicuspid
In this episode of the DrBicuspid.com podcast, Kevin Henry speaks with Dr. Yoon Hong Cheol and Dr. Mike Miyasaki about the innovative biofluorescence technology developed by AIOBIO. They discuss the shift from reactive to preventive dentistry, the importance of building trust with patients through visual tools, and the commitment required for success in the dental field. The conversation also touches on the goals for 2026, focusing on expanding the use of biofluorescence technology in the United States.
Learn more at https://www.aiobio.com/home
